Identification of key bioactive compounds of medicine-food homologous substances and their multi-target intervention effects in ulcerative colitis treatment | Synapse
March 3, 2026
Identification of key bioactive compounds of medicine-food homologous substances and their multi-target intervention effects in ulcerative colitis treatment
Key Points
Bioactive compounds demonstrate significant treatment effects in ulcerative colitis, offering potential new therapeutic options.
The study highlights the role of multi-target interventions that might improve treatment outcomes for ulcerative colitis.
Analysis of bioactive compounds focuses on their efficacy in reducing inflammation and promoting gut health.
This work supports the idea that integrating food-based therapies could enhance existing treatments for ulcerative colitis.